发明名称 |
USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT |
摘要 |
Leptin, leptin analogs, and leptin derivatives are used to treat patients wi th lipodystrophy. Leptin is effective against lipodystrophy conditions for both genetic and acquired forms of the disease. A therapeutically effective amoun t of leptin can be administered in a variety of ways, including in a vector comprising nucleic acid sequences encoding leptin. Methods of the present invention contemplate administration of leptin, leptin analogs, and leptin derivatives to patients having approximately 4 ng/ml or less before treatmen t. |
申请公布号 |
CA2464277(A1) |
申请公布日期 |
2003.05.01 |
申请号 |
CA20022464277 |
申请日期 |
2002.10.22 |
申请人 |
AMGEN, INC. |
发明人 |
DEPAOLI, ALEX M.;ORAL, ELIF ARIOGLU;GARG, ABHIMANYU;TAYLOR, SIMEON I. |
分类号 |
G01N33/53;A61K38/22;A61K38/55;A61K45/00;A61P3/04;A61P3/10;A61P43/00;G01N33/74;(IPC1-7):G01N33/53;A61K38/16;A61K38/19 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|